"Centro médico con más de 22 años de experiencia. Contamos con neumonología de adultos y padiatrica, dermatología y estetica, cardiología, ORL y reumatología. Insares ofrece equipamiento de última tecnología y profesionales de excelencia."

During the past decade, INSARES conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "INSARES" are "Lung Diseases, Interstitial" (4 trials), "Asthma" (3 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "INSARES" in a lesser frequency.

Most popular intervention types in "INSARES" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Nintedanib" (3 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Astegolimab" (1 trials) and "BIBF 1120" (1 trials). Other intervention names were less common.

The vast majority of trials in "INSARES" are 11 trials for "All" genders.

Currently, there are NaN active trials in "INSARES". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in INSARES, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in INSARES, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".